S&P 500   3,335.47 (-0.48%)
DOW   27,452.66 (-0.48%)
QQQ   275.95 (-0.45%)
AAPL   114.09 (-0.76%)
MSFT   207.26 (-1.04%)
FB   261.79 (+1.94%)
GOOGL   1,466.02 (+0.50%)
AMZN   3,144.88 (-0.92%)
TSLA   419.07 (-0.51%)
NVDA   529.03 (+1.46%)
BABA   276.93 (+0.33%)
CGC   14.50 (+2.04%)
GE   6.12 (-1.29%)
MU   50.71 (+1.99%)
AMD   81.77 (+2.88%)
T   28.30 (-0.28%)
F   6.60 (-1.35%)
ACB   4.68 (-2.09%)
GILD   62.10 (-1.19%)
NFLX   493.48 (+0.58%)
DIS   125.40 (-0.47%)
BA   163.60 (-1.49%)
BAC   23.77 (-1.33%)
S&P 500   3,335.47 (-0.48%)
DOW   27,452.66 (-0.48%)
QQQ   275.95 (-0.45%)
AAPL   114.09 (-0.76%)
MSFT   207.26 (-1.04%)
FB   261.79 (+1.94%)
GOOGL   1,466.02 (+0.50%)
AMZN   3,144.88 (-0.92%)
TSLA   419.07 (-0.51%)
NVDA   529.03 (+1.46%)
BABA   276.93 (+0.33%)
CGC   14.50 (+2.04%)
GE   6.12 (-1.29%)
MU   50.71 (+1.99%)
AMD   81.77 (+2.88%)
T   28.30 (-0.28%)
F   6.60 (-1.35%)
ACB   4.68 (-2.09%)
GILD   62.10 (-1.19%)
NFLX   493.48 (+0.58%)
DIS   125.40 (-0.47%)
BA   163.60 (-1.49%)
BAC   23.77 (-1.33%)
S&P 500   3,335.47 (-0.48%)
DOW   27,452.66 (-0.48%)
QQQ   275.95 (-0.45%)
AAPL   114.09 (-0.76%)
MSFT   207.26 (-1.04%)
FB   261.79 (+1.94%)
GOOGL   1,466.02 (+0.50%)
AMZN   3,144.88 (-0.92%)
TSLA   419.07 (-0.51%)
NVDA   529.03 (+1.46%)
BABA   276.93 (+0.33%)
CGC   14.50 (+2.04%)
GE   6.12 (-1.29%)
MU   50.71 (+1.99%)
AMD   81.77 (+2.88%)
T   28.30 (-0.28%)
F   6.60 (-1.35%)
ACB   4.68 (-2.09%)
GILD   62.10 (-1.19%)
NFLX   493.48 (+0.58%)
DIS   125.40 (-0.47%)
BA   163.60 (-1.49%)
BAC   23.77 (-1.33%)
S&P 500   3,335.47 (-0.48%)
DOW   27,452.66 (-0.48%)
QQQ   275.95 (-0.45%)
AAPL   114.09 (-0.76%)
MSFT   207.26 (-1.04%)
FB   261.79 (+1.94%)
GOOGL   1,466.02 (+0.50%)
AMZN   3,144.88 (-0.92%)
TSLA   419.07 (-0.51%)
NVDA   529.03 (+1.46%)
BABA   276.93 (+0.33%)
CGC   14.50 (+2.04%)
GE   6.12 (-1.29%)
MU   50.71 (+1.99%)
AMD   81.77 (+2.88%)
T   28.30 (-0.28%)
F   6.60 (-1.35%)
ACB   4.68 (-2.09%)
GILD   62.10 (-1.19%)
NFLX   493.48 (+0.58%)
DIS   125.40 (-0.47%)
BA   163.60 (-1.49%)
BAC   23.77 (-1.33%)
Log in
NASDAQ:NVUS

Novus Therapeutics SEC Filings & 10K Form

$0.98
+0.02 (+2.00 %)
(As of 09/29/2020 04:44 PM ET)
Add
Compare
Today's Range
$0.97
Now: $0.98
$1.05
50-Day Range
$0.38
MA: $0.56
$1.11
52-Week Range
$0.25
Now: $0.98
$1.45
Volume794,968 shs
Average Volume1.72 million shs
Market Capitalization$19.00 million
P/E RatioN/A
Dividend YieldN/A
Beta3.12

SEC Filings

Novus Therapeutics (NASDAQ:NVUS) SEC Filings

DateFilerForm TypeView
09/25/2020
2:31 PM
Novus Therapeutics (Filer)
Form D
Notice of Exempt Offering of Securities 
09/24/2020
6:44 PM
Novus Therapeutics (Issuer)
Perrin Steven (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/24/2020
6:44 PM
Novus Therapeutics (Issuer)
Ogier Walter C (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/15/2020
7:18 PM
LYONS GARY A (Reporting)
Novus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/15/2020
7:13 PM
Kuwahara Jon (Reporting)
Novus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/15/2020
7:12 PM
Gros David-Alexandre C (Reporting)
Novus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/15/2020
7:10 PM
Katkin Keith (Reporting)
Novus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/15/2020
7:10 PM
McBride John S. (Reporting)
Novus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/15/2020
7:06 PM
Gros David-Alexandre C (Reporting)
Novus Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/15/2020
4:19 PM
Novus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/15/2020
2:14 PM
Novus Therapeutics (Filer)
Form 424B3
09/04/2020
3:25 PM
Novus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/18/2020
3:35 PM
Novus Therapeutics (Subject)
OrbiMed Israel BioFund GP Limited Partnership (Filed by)
Form SC 13D/A
05/15/2020
5:32 AM
Novus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2020
5:02 AM
Novus Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/13/2020
3:00 PM
Novus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/23/2020
5:03 AM
Novus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/05/2020
11:15 PM
Novus Therapeutics (Filer)
Form EFFECT
03/25/2020
3:16 PM
Novus Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/25/2020
3:06 PM
Novus Therapeutics (Filer)
Form S-1
Registration statement under Securities Act of 1933  
03/20/2020
3:31 PM
FLESHER GREGORY J. (Reporting)
Novus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2020
3:31 PM
Novus Therapeutics (Issuer)
TURKEL CATHERINE C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2020
3:30 PM
Kuwahara Jon (Reporting)
Novus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/17/2020
5:03 AM
Novus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/25/2020
4:17 PM
Novus Therapeutics (Issuer)
OrbiMed Israel BioFund GP Limited Partnership (Reporting)
OrbiMed Israel GP Ltd. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2020
4:04 PM
Novus Therapeutics (Subject)
OrbiMed Israel BioFund GP Limited Partnership (Filed by)
Form SC 13D/A
02/20/2020
5:12 AM
Novus Therapeutics (Filer)
Form 8-K/A
02/13/2020
8:52 AM
683 Capital Management, LLC (Filed by)
Novus Therapeutics (Subject)
Form SC 13G/A
01/27/2020
3:30 PM
Novus Therapeutics (Filer)
Form D
Notice of Exempt Offering of Securities 
01/16/2020
3:31 PM
Novus Therapeutics (Filer)
Form 424B3
01/16/2020
5:32 AM
Novus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/14/2020
3:28 PM
Novus Therapeutics (Filer)
Form 424B3
11/13/2019
5:00 AM
Novus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/30/2019
8:30 PM
Kuwahara Jon (Reporting)
Novus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2019
8:30 PM
Novus Therapeutics (Issuer)
TURKEL CATHERINE C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2019
8:30 PM
FLESHER GREGORY J. (Reporting)
Novus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/09/2019
4:30 PM
Novus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/26/2019
1:48 PM
683 Capital Management, LLC (Filed by)
Novus Therapeutics (Subject)
Form SC 13G
07/15/2019
3:06 PM
McBride John S. (Reporting)
Novus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/15/2019
3:05 PM
Katkin Keith (Reporting)
Novus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/15/2019
3:05 PM
Chimovits Erez (Reporting)
Novus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/15/2019
3:05 PM
LYONS GARY A (Reporting)
Novus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/15/2019
3:05 PM
Cohen Cheryl (Reporting)
Novus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/12/2019
3:05 PM
Novus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/28/2019
3:08 PM
Novus Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
06/17/2019
11:15 PM
Novus Therapeutics (Filer)
Form EFFECT
06/07/2019
3:07 PM
Novus Therapeutics (Filer)
Form S-1
Registration statement under Securities Act of 1933  
06/05/2019
1:59 PM
ARMISTICE CAPITAL, LLC (Filed by)
Novus Therapeutics (Subject)
Form SC 13G
05/22/2019
3:12 PM
Novus Therapeutics (Issuer)
TURKEL CATHERINE C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2019
3:02 PM
Kuwahara Jon (Reporting)
Novus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2019
3:01 PM
FLESHER GREGORY J. (Reporting)
Novus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2019
3:33 PM
Novus Therapeutics (Filer)
Form DEFA14A
05/15/2019
3:30 PM
Novus Therapeutics (Filer)
Form DEF 14A
05/10/2019
3:24 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Novus Therapeutics (Subject)
Form SC 13G
05/10/2019
3:01 PM
Novus Therapeutics (Filer)
Form D
Notice of Exempt Offering of Securities 
05/06/2019
4:30 PM
Novus Therapeutics (Issuer)
OrbiMed Israel BioFund GP Limited Partnership (Reporting)
OrbiMed Israel GP Ltd. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2019
4:28 PM
Chimovits Erez (Reporting)
Novus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2019
4:01 PM
Novus Therapeutics (Subject)
OrbiMed Israel BioFund GP Limited Partnership (Filed by)
Form SC 13D/A
05/02/2019
3:47 PM
LIFESCI INDEX PARTNERS LLC (Reporting)
Novus Therapeutics (Issuer)
YOOK PAUL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2019
3:24 PM
Novus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/01/2019
5:07 AM
Novus Therapeutics (Filer)
Form 424B5
04/30/2019
3:05 PM
Novus Therapeutics (Filer)
Form 10-K/A
04/22/2019
7:02 AM
Novus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/05/2019
6:32 AM
Novartis Bioventures Ltd (Filed by)
Novus Therapeutics (Subject)
Form SC 13D/A
03/28/2019
5:04 AM
Novus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/18/2019
3:23 PM
Kuwahara Jon (Reporting)
Novus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2019
11:49 AM
Novus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2018
6:58 AM
Novus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/13/2018
7:00 PM
Novus Therapeutics (Issuer)
TURKEL CATHERINE C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/07/2018
7:00 PM
Novus Therapeutics (Issuer)
TURKEL CATHERINE C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/07/2018
8:00 AM
Novus Therapeutics (Filer)
Form RW
09/04/2018
3:38 PM
Novus Therapeutics (Filer)
Form S-1/A
08/07/2018
7:31 AM
Novus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/31/2018
11:15 PM
Novus Therapeutics (Filer)
Form EFFECT
07/23/2018
3:08 PM
Novus Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
06/14/2018
4:54 PM
Cohen Cheryl (Reporting)
Novus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2018
4:53 PM
LYONS GARY A (Reporting)
Novus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2018
4:52 PM
Katkin Keith (Reporting)
Novus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2018
4:52 PM
McBride John S. (Reporting)
Novus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2018
4:24 PM
Novus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2018
3:22 PM
APPLE TREE PARTNERS II LP (Filed by)
Novus Therapeutics (Subject)
Form SC 13D/A
04/30/2018
12:12 PM
Novus Therapeutics (Filer)
Form DEFA14A
04/30/2018
12:03 PM
Novus Therapeutics (Filer)
Form DEF 14A
04/17/2018
3:21 PM
Novartis Bioventures Ltd (Filed by)
Novus Therapeutics (Subject)
Form SC 13D/A
03/30/2018
8:54 PM
Novus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/30/2018
8:46 PM
Novus Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/20/2018
1:17 PM
LIFESCI INDEX PARTNERS LLC (Reporting)
Novus Therapeutics (Issuer)
YOOK PAUL (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/19/2018
2:16 PM
Novus Therapeutics (Subject)
OrbiMed Israel BioFund GP Limited Partnership (Filed by)
Form SC 13D/A
03/15/2018
5:53 PM
Kuwahara Jon (Reporting)
Novus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/15/2018
5:51 PM
FLESHER GREGORY J. (Reporting)
Novus Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/15/2018
5:46 PM
Novus Therapeutics (Issuer)
TURKEL CATHERINE C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2018
11:12 AM
LIFESCI INDEX PARTNERS LLC (Filed by)
Novus Therapeutics (Subject)
Form SC 13G
01/08/2018
4:11 PM
APPLE TREE PARTNERS II LP (Filed by)
Novus Therapeutics (Subject)
Form SC 13D/A
11/29/2017
4:00 PM
Novus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
This page was last updated on 9/29/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.